Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorizationís                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
Our client, the Head of Development of a global pharmaceutical company in a post-merger situation, sought to build a world class development capability. Differences in legacy company cultures had to be overcome.Garphi and another associate were subsequently selected to assist in the change process.Using our associatesí change management methodology and the existing diagnostic to execute design, implementation and benefits realization phases, the project had complementary work streams to:
  • Streamline development decision-making
  • Establish effective teams for delivery of clinical development programs
  • Optimize key clinical trial planning, and management processes
  • Garphi was successful in establishing new ways of working owned by the whole merged development organization, not linked to one legacy, but also ensure increased reliability of clinical development program timelines, cost reductions and resource optimization.